Malaria drug sees promising signs as future coronavirus treatment
A drug originally developed to treat malaria is showing signs that it may also cure infections of the coronavirus, though much more testing is needed.
Researchers and virologists in France have completed a clinical trial studying the effects of hydroxychloroquine, used to treat arthritis, malaria, and other ailments, on patients with COVID-19. Researchers treated a total of 26 coronavirus patients with the drug, including six that were given the antibiotic azithromycin, as well.
The researchers released their findings in a study published on Wednesday.